Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply 'hyperfibrinolysis'.
作者信息
Hardy M, Bareille M, Lecompte T, Mullier F
机构信息
Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Hematology Laboratory, Yvoir, Belgium.
Université de Lorraine, Nancy, France; Université de Namur, Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium.
出版信息
Thromb Res. 2022 Jun;214:63-64. doi: 10.1016/j.thromres.2022.04.012. Epub 2022 Apr 25.
Abstract
摘要
相似文献
1
Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply 'hyperfibrinolysis'.别被D-二聚体误导：血浆D-二聚体水平升高并不意味着“高纤维蛋白溶解”。
Thromb Res. 2022 Jun;214:63-64. doi: 10.1016/j.thromres.2022.04.012. Epub 2022 Apr 25.
2
Enhanced fibrinolysis detection in a natural occurring canine model with intracavitary effusions: Comparison and degree of agreement between thromboelastometry and FDPs, D-dimer and fibrinogen concentrations.腔内积液的自然发生犬模型中增强的纤维蛋白溶解检测：血栓弹力描记术与 FDPs、D-二聚体和纤维蛋白原浓度的比较和一致性程度。
PLoS One. 2019 Nov 14;14(11):e0225089. doi: 10.1371/journal.pone.0225089. eCollection 2019.
3
Association between ascites and primary hyperfibrinolysis: A cohort study in 210 dogs.腹水与原发性纤溶亢进之间的关联：一项对210只犬的队列研究。
Vet J. 2017 May;223:12-20. doi: 10.1016/j.tvjl.2017.03.008. Epub 2017 Mar 31.
4
A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.活化凝血和/或纤维蛋白溶解标志物检测方法的比较评估：凝血酶 - 抗凝血酶复合物、D - 二聚体和纤维蛋白原/纤维蛋白片段E抗原
Br J Haematol. 1990 Apr;74(4):471-9. doi: 10.1111/j.1365-2141.1990.tb06337.x.
5
D-dimer and its relationship to fibrinogen/fibrin degradation products (FDPs) in disorders associated with activation of coagulation or fibrinolytic systems.D-二聚体及其在与凝血或纤溶系统激活相关疾病中与纤维蛋白原/纤维蛋白降解产物（FDPs）的关系。
J Clin Lab Anal. 2003;17(3):77-9. doi: 10.1002/jcla.10072.
6
7
Is it possible to make a common reference standard for D-dimer measurements? Communication from the ISTH SSC Subcommittee on Fibrinolysis.是否有可能为 D-二聚体测量制定一个通用参考标准？国际血栓与止血学会 SSC 纤溶小组委员会的交流。
J Thromb Haemost. 2022 Feb;20(2):498-507. doi: 10.1111/jth.15555. Epub 2021 Nov 24.
8
Characterization of fibrin/fibrinogen degradation products reagents and their utility in critical care patients with enhanced fibrinolysis.纤维蛋白/纤维蛋白原降解产物试剂的特性及其在伴有纤维蛋白溶解增强的重症监护患者中的应用。
Int J Lab Hematol. 2021 Aug;43(4):813-820. doi: 10.1111/ijlh.13428. Epub 2020 Dec 10.
9
Coagulation and fibrinolysis disorder in muscular dystrophy.肌肉萎缩症中的凝血与纤维蛋白溶解紊乱
Muscle Nerve. 2001 Mar;24(3):399-402. doi: 10.1002/1097-4598(200103)24:3<399::aid-mus1012>3.0.co;2-b.
10
Coagulopathy and Traumatic Brain Injury: Overview of New Diagnostic and Therapeutic Strategies.凝血障碍与创伤性脑损伤：新的诊断与治疗策略概述。
Neurol Med Chir (Tokyo). 2022 Jun 15;62(6):261-269. doi: 10.2176/jns-nmc.2022-0018. Epub 2022 Apr 22.
引用本文的文献
1
Utility of fibrinolysis enhanced viscoelastic assays to evaluate fibrinolysis disorders in critically ill adults with severe infection: a scoping review.纤维蛋白溶解增强粘弹性测定法在评估重症感染成年危重症患者纤维蛋白溶解障碍中的应用：一项范围综述
Ann Intensive Care. 2025 Jul 31;15(1):110. doi: 10.1186/s13613-025-01528-x.
2
Coagulation Disorders in Sepsis and COVID-19-Two Sides of the Same Coin? A Review of Inflammation-Coagulation Crosstalk in Bacterial Sepsis and COVID-19.脓毒症和新冠肺炎中的凝血障碍——同一枚硬币的两面？细菌感染性脓毒症和新冠肺炎中炎症与凝血相互作用的综述
J Clin Med. 2023 Jan 11;12(2):601. doi: 10.3390/jcm12020601.
3
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study.使用ClotPro®进行粘弹性测试对接受或未接受体外膜肺氧合（ECMO）治疗的重症新型冠状病毒肺炎急性呼吸窘迫综合征（Covid-19 ARDS）患者短期预后的预测能力：一项回顾性研究
Thromb J. 2022 Aug 29;20(1):48. doi: 10.1186/s12959-022-00403-0.
本文引用的文献
1
Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?重症新型冠状病毒肺炎（COVID-19）是发生了高纤维蛋白溶解还是纤维蛋白溶解关闭？
Thromb Res. 2022 Feb;210:1-3. doi: 10.1016/j.thromres.2021.12.012. Epub 2021 Dec 20.
2
Could Daily Monitoring of Fibrin Related Markers Help Suspect a Thrombotic Event in COVID-19 Patients? A Prospective Pilot Study.每日监测纤维蛋白相关标志物能否有助于怀疑COVID-19患者发生血栓形成事件？一项前瞻性试点研究。
TH Open. 2021 May 12;5(2):e152-e154. doi: 10.1055/s-0041-1728722. eCollection 2021 Apr.
3
Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review.用于评估新型冠状病毒肺炎止血功能的粘弹性测试：一项系统评价
J Clin Med. 2021 Apr 16;10(8):1740. doi: 10.3390/jcm10081740.
4
Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study.重症新型冠状病毒肺炎患者止血的血栓前状态紊乱：一项前瞻性纵向观察研究。
Thromb Res. 2021 Jan;197:20-23. doi: 10.1016/j.thromres.2020.10.025. Epub 2020 Oct 24.
5
Histopathological observations in COVID-19: a systematic review.新型冠状病毒肺炎的组织病理学观察：一项系统综述
J Clin Pathol. 2021 Feb;74(2):76-83. doi: 10.1136/jclinpath-2020-206995. Epub 2020 Aug 18.
6
All those D-dimers in COVID-19.新冠病毒感染病例中的所有这些D-二聚体。
J Thromb Haemost. 2020 Aug;18(8):2075-2076. doi: 10.1111/jth.14939. Epub 2020 Jun 25.
7
Defining trauma-induced coagulopathy with respect to future implications for patient management: Communication from the SSC of the ISTH.关于创伤性凝血病对患者管理的未来影响的定义：来自国际血栓与止血学会科学与标准化委员会的沟通
J Thromb Haemost. 2020 Mar;18(3):740-747. doi: 10.1111/jth.14690.
8
The current status of viscoelastic testing in septic coagulopathy.脓毒症凝血障碍中黏弹性检测的现状。
Thromb Res. 2019 Nov;183:146-152. doi: 10.1016/j.thromres.2019.09.029. Epub 2019 Oct 23.
9
Review of D-dimer testing: Good, Bad, and Ugly.D-二聚体检测综述：优点、缺点与不足
Int J Lab Hematol. 2017 May;39 Suppl 1:98-103. doi: 10.1111/ijlh.12665.
10
Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity.一种改良血栓弹力图检测纤溶活性变化方法的验证
Thromb J. 2016 Jan 14;14:1. doi: 10.1186/s12959-016-0076-2. eCollection 2016.
Zotero 插件